Cocrystal Pharma, Inc. Quarterly Depreciation in USD from Q3 2010 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Cocrystal Pharma, Inc. quarterly/annual Depreciation history and growth rate from Q3 2010 to Q1 2023.
  • Cocrystal Pharma, Inc. Depreciation for the quarter ending March 31, 2023 was $45K.
  • Cocrystal Pharma, Inc. annual Depreciation for 2018 was $50K, a 50.5% decline from 2017.
  • Cocrystal Pharma, Inc. annual Depreciation for 2017 was $101K, a 49.8% decline from 2016.
  • Cocrystal Pharma, Inc. annual Depreciation for 2016 was $201K, a 4.69% increase from 2015.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $45K Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q1 2019 $23K +$8K +53.3% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-10
Q1 2018 $15K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q1 2016 $56K +$11K +24.4% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-10
Q1 2015 $45K -$12K -21.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q1 2014 $57K -$3K -5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q1 2013 $60K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q3 2011 $205K +$117K +134% Jul 1, 2011 Sep 30, 2011 10-Q 2011-11-21
Q3 2010 $87.9K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.